Sopharma To Invest 60 Million Euro in 2008 and 2009

288
Sopharma To Invest 60 Million Euro in 2008 and 2009

Sopharma Jsc is planning to invest some 60 million euros in 2008 and 2009, the company's annual report filed with BSE-Sofia reveals.

The pharmaceutical company expects a 10-12% hike in sales revenues this year and a 20-25% increase in pre-tax profit.

Sopharma posted net profit in the amount of 30.63 million leva (15.66 million euros) last year, which is 39% up from 2006 (22.034 million leva,).

42% of sales revenues last year came from sales on the domestic market. Exports accounted for 64.828 million leva, which is 41% up from 2006. The relative share of sales abroad stood at 52%, compared with 52% in 2006.

89% of exports are to Russia, Ukraine, Poland, Kazakhstan and Belarus.

This year Sopharma Jsc received a First Class Investment Certificate for its 37.65 million euro project for the construction of a medical plant.

Main shareholders are Donev investments and Telso Jsc which control 25.64% and 23.77% respectively. Telecomplect and Greamery Emerging Market Fund have 20.42% and 17.08%.

Photo: BGNES

Facebook Коментари

Добави коментар

Екипът на Profit.bg Ви благодари, че използвате кирилица за вашите коментари.
В случай, че коментарът Ви съдържа нецензурни квалификации и лични нападки или обиди на расова, сексуална, етническа или верска основа, той ще бъде изтрит от модератора на сайта.

Абонирайте се за електронния
информационен бюлетин на Profit.bg